49 results
Keyword vaxzevria Remove keyword
Type of content
News Remove News filter
Categories
Human Remove Human filter
-
List item
News: EMA recommends approval of VidPrevtyn Beta as a COVID 19 booster vaccine
CHMP, Last updated: 11/11/2022adenoviral vector vaccine (Vaxzevria or Jcovden). The Committee … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 10-13 October 2022
CHMP, Last updated: 14/10/2022Vaxzevria … -
List item
News: EMA recommends Valneva’s COVID-19 vaccine for authorisation in the EU
CHMP, Last updated: 23/06/2022SARS-CoV-2 than the comparator, Vaxzevria. In addition, the proportion … at least as effective as Vaxzevria at protecting against the … -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 7-10 June 2022
PRAC, Last updated: 10/06/2022 -
List item
News: EMA adopts first list of critical medicines for COVID-19
Last updated: 08/06/2022injection Parenteral All Vaxzevria (previously COVID-19 Vaccine … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 16-19 May 2022
CHMP, Last updated: 20/05/2022Vaxzevria … -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 4-7 April 2022
PRAC, Last updated: 08/04/2022ChAdOx1-S [recombinant]) - VAXZEVRIA (CAP) .......... 13 4.1.2 … -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 7 - 10 February 2022
PRAC, Last updated: 11/02/2022 -
List item
News: Increase in manufacturing capacity for Vaxzevria (previously COVID-19 Vaccine AstraZeneca)
CHMP, Last updated: 24/01/2022manufacturing capacity for Vaxzevria (previously COVID-19 Vaccine … manufacturing capacity for Vaxzevria (previously COVID-19 Vaccine … -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10 - 13 January 2022
PRAC, Last updated: 14/01/2022Vaxzevria and COVID-19 Vaccine Janssen … -
List item
News: EMA and ECDC recommendations on heterologous vaccination courses against COVID-19: ‘mix-and-match’ approach can be used for both initial courses and boosters
Last updated: 07/12/2021is greater and faster for Vaxzevria than other regimens and that … vaccinating with a first dose of Vaxzevria followed by a second dose … syndrome (TTS) following Vaxzevria. This decision by public health … -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 29 November - 2 December 2021
PRAC, Last updated: 03/12/2021 -
List item
News: Increase in manufacturing capacity for COVID-19 vaccine from AstraZeneca
CHMP, Last updated: 01/12/2021a new site to manufacture Vaxzevria (previously COVID-19 Vaccine … support the continued supply of Vaxzevria in the European Union and … -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 25-28 October 2021
PRAC, Last updated: 29/10/2021 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 27-30 September 2021
PRAC, Last updated: 01/10/2021immune thrombocytopenia with Vaxzevria and COVID-19 Vaccine Janssen … following vaccination with Vaxzevria (formerly AstraZeneca COVID-19 … COVID-19 Vaccine Janssen or Vaxzevria. If an individual has a history … -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 30 August – 2 September 2021
PRAC, Last updated: 17/09/2021Comirnaty: 5; Spikevax: 1; Vaxzevria: no case; COVID-19 Vaccine … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 13-16 September 2021
CHMP, Last updated: 17/09/2021concludes Article 5(3) review on Vaxzevria The Committee for Medicinal … the use of a second dose of Vaxzevria, reinforcing its interim opinion … continue giving a second dose of Vaxzevria between 4 and 12 weeks after … -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 5 August 2021
PRAC, Last updated: 06/08/2021Guillain-Barré syndrome with Vaxzevria … -
List item
News: COVID-19 Vaccine Janssen: Guillain-Barré syndrome listed as a very rare side effect
PRAC, Last updated: 22/07/2021taken place recently for Vaxzevria (previously COVID-19 Vaccine … requirements'. product information of Vaxzevria now includes a warning on … -
List item
News: EMA and ECDC update on COVID-19
Last updated: 14/07/2021like Comirnaty, Spikevax or Vaxzevria are needed to provide adequate … adenoviral vector vaccine, Vaxzevria. A heterologous vaccination … for Comirnaty, Spikevax or Vaxzevria, one dose with COVID-19 Vaccine … -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 5-8 July 2021
PRAC, Last updated: 09/07/2021public health communication . Vaxzevria: warning for Guillain-Barre … -
List item
News: Comirnaty and Spikevax: possible link to very rare cases of myocarditis and pericarditis
PRAC, Last updated: 09/07/2021COVID-19 Vaccine Janssen and Vaxzevria 1 , and the Committee has … -
List item
News: EMA advises against use of COVID-19 Vaccine Janssen in people with history of capillary leak syndrome
PRAC, Last updated: 09/07/2021another COVID-19 vaccine, Vaxzevria (previously COVID-19 Vaccine … -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 7-10 June 2021
PRAC, Last updated: 11/06/2021syndrome with COVID-19 vaccine Vaxzevria EMA’s safety committee … must not be vaccinated with Vaxzevria (formerly COVID-19 Vaccine … in people who had received Vaxzevria 1 . Most of the cases occurred … -
List item
News: COVID-19 vaccines: update on ongoing evaluation of myocarditis and pericarditis
PRAC, Last updated: 11/06/2021defend the body against it. Vaxzevria and COVID-19 Vaccine Janssen … further investigation. For Vaxzevria and COVID-19 Vaccine Janssen … COVID-19 Vaccine Moderna), 38 (Vaxzevria) and 0 for COVID-19 Vaccine …